0001437749-23-004241.txt : 20230222
0001437749-23-004241.hdr.sgml : 20230222
20230222183505
ACCESSION NUMBER: 0001437749-23-004241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230218
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berger Mark Stanley
CENTRAL INDEX KEY: 0001700283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38244
FILM NUMBER: 23655199
MAIL ADDRESS:
STREET 1: 140 RIVERSIDE DRIVE
STREET 2: APT. 9K
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genprex, Inc.
CENTRAL INDEX KEY: 0001595248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900772347
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
BUSINESS PHONE: 512-537-7997
MAIL ADDRESS:
STREET 1: 1601 TRINITY STREET, BLDG. B
STREET 2: SUITE 3.322
CITY: AUSTIN
STATE: TX
ZIP: 78712
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-02-18
0001595248
Genprex, Inc.
GNPX
0001700283
Berger Mark Stanley
3300 BEE CAVE ROAD
#650-227
AUSTIN
TX
78746
1
Chief Medical Officer
Common Stock
2023-02-18
4
A
0
245000
0
A
245000
D
This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis.
/s/ Catherine Vaczy as Attorney-in-Fact for Mark Berger
2023-02-22